Turkey starts giving Turkovac as booster shot to BioNTech recipients

Turkey has started to give the locally developed inactivated vaccine, Turkovac, as a booster shot to those who have already received two doses of the Pfizer/BioNTech mRNA jab.

Health Minister Fahrettin Koca previously said that for the first time in the world the recipients of an mRNA vaccine would be given an inactivated jab as a booster shot to observe how the antibody level changes.

The study will be carried out in five centers in Ankara, Istanbul and İzmir on a total of 1,034 volunteers, and this phase-two B study will last for three months, according to İhsan Ateş, chief physician at the Ankara City Hospital, who is also the coordinator of the study.

"The Turkovac vaccine will be given to those who received two doses of the Pfizer/BioNTech jab at least 90 days ago," he said.

Ateş also noted that toward the end of the week the homegrown vaccine will start to be given to adolescents and next week to pregnant women.

After authorities approved the local vaccine for emergency use Turkey rolled out the jab at the end of December 2021.

In its inoculation drive, which was launched in January last year, beside Turkovac and the Pfizer/BioNTech vaccines, the country is also using the inactivated shot developed by the Chinese company Sinovac.

To date, the country has administered more than 140 million doses of the COVID-19 vaccines, with over 24 million people having received a booster shot.

According to data from the health minister, more than 52 million adults, or 84 percent of the population aged 18 and over, have been double jabbed and 57 million people from the same age group have received at least one dose of the vaccine.

Meanwhile, Koca yesterday unveiled the weekly incidence rate data, measuring the...